| Stroke recurrence, n (%) | Univariate analyses | |||
---|---|---|---|---|---|
 | Yes (n = 28) | No (n = 125) | P value | HR (95 % CI) | P value |
Age ≥ 65 years | 15(53.6) | 58(46.4) | 0.535 | 1.3(0.6-2.8) | 0.445 |
Male | 21(75) | 85(68) | 0.651 | 1.4(0.6-3.3) | 0.459 |
Hypertension | 22(78.6) | 84(67.2) | 0.267 | 1.7(0.7-4.1) | 0.276 |
Hypercholesterolemia | 12(42.9) | 63(50.4) | 0.534 | 0.8(0.4-1.6) | 0.487 |
Diabetes mellitus | 10(35.7) | 52(41.6) | 0.672 | 0.8(0.4-1.8) | 0.603 |
Smoking | 15(53.6) | 57(45.6) | 0.531 | 1.3(0.6-2.8) | 0.438 |
Asymptomatic ICAS | 15(53.6) | 59(47.2) | 0.676 | 1.3(0.6-2.7) | 0.514 |
Distributions of cerebral infarctions | Â | Â | Â | Â | Â |
 Perforating artery infarctions | 9(32.1) | 59(47.2) | 0.207 | 0.6(0.3-1.3) | 0.168 |
 Cortical infarctions | 16(57.1) | 62(49.6) | 0.534 | 1.6(0.7-3.4) | 0.241 |
 Internal border-zone infarctions | 16(57.1) | 64(51.2) | 0.677 | 1.3(0.6-2.8) | 0.438 |
NIHSS score at admission ≥ 4 | 11(39.3) | 62(49.6) | 0.404 | 0.9(0.4-2.0) | 0.855 |
Poor MCA branch signal intensity | 25(89.3) | 93(74.4) | 0.134 | 2.8(0.8-9.3) | 0.091 |
 Grade C | 18(64.3) | 42(33.6) | 0.005 | 3.2(1.5-6.9) | 0.003 |
Discontinued antiplatelet drug | 1(3.6) | 6(4.8) | 1.000 | 0.5(0.1-3.6) | 0.481 |
Discontinued statin | 4(14.3) | 13(10.4) | 0.554 | 1.2(0.4-3.1) | 0.759 |